University of Pennsylvania-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2020

  1. Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study

    Journal of Veterinary Internal Medicine, Vol. 34, Núm. 3, pp. 1108-1118

2019

  1. Long-term incidence and risk of noncardiovascular and all-cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy

    Journal of Veterinary Internal Medicine, Vol. 33, Núm. 6, pp. 2572-2586

2018

  1. International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study

    Journal of Veterinary Internal Medicine, Vol. 32, Núm. 3, pp. 930-943

  2. Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study

    Journal of Veterinary Internal Medicine, Vol. 32, Núm. 1, pp. 72-85

2017

  1. Die Wirkung von Pimobendan bei Hunden mit praklinischer myxomatoser Mitralklappen- erkrankung und Kardiomegalie: Die EPIC-Studie - Eine randomisierte klinische Studie

    Kleintierpraxis, Vol. 62, Núm. 2, pp. 64-87

2016

  1. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial

    Journal of Veterinary Internal Medicine, Vol. 30, Núm. 6, pp. 1765-1779

2008

  1. Perioperative stress response in dogs undergoing elective surgery: Variations in behavioural, neuroendocrine, immune and acute phase responses

    Animal Welfare, Vol. 17, Núm. 3, pp. 259-273